These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1727739)

  • 1. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats.
    Yagihashi S; Kamijo M; Baba M; Yagihashi N; Nagai K
    Diabetes; 1992 Jan; 41(1):47-52. PubMed ID: 1727739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats.
    Miyauchi Y; Shikama H; Takasu T; Okamiya H; Umeda M; Hirasaki E; Ohhata I; Nakayama H; Nakagawa S
    Eur J Endocrinol; 1996 Apr; 134(4):467-73. PubMed ID: 8640299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.
    Kato N; Mizuno K; Makino M; Suzuki T; Yagihashi S
    Diabetes Res Clin Pract; 2000 Oct; 50(2):77-85. PubMed ID: 10960717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats.
    Aggarwal M; Singh J; Sood S; Arora B
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):131-4. PubMed ID: 11523311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Sakata Y; Muto G; Muto Y; Takahashi K; Toyota T
    Diabetologia; 1998 Nov; 41(11):1321-6. PubMed ID: 9833940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lacidipine pre-treatment on diabetic neuropathy in rats.
    Singh J; Aditya S; Lal H; Arora B
    Arch Physiol Biochem; 2011 Feb; 117(1):12-7. PubMed ID: 21091185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
    Sima AA; Prashar A; Zhang WX; Chakrabarti S; Greene DA
    J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
    Naka K; Sasaki H; Kishi Y; Furuta M; Sanke T; Nanjo K; Mukoyama M
    Diabetes Res Clin Pract; 1995 Dec; 30(3):153-62. PubMed ID: 8861454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural abnormalities in the nerves of type I diabetic baboons: aminoguanidine treatment does not improve nerve function.
    Birrell AM; Heffernan SJ; Ansselin AD; McLennan S; Church DK; Gillin AG; Yue DK
    Diabetologia; 2000 Jan; 43(1):110-6. PubMed ID: 10672451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral nerve structure and function in experimental diabetes.
    Sharma AK; Thomas PK
    J Neurol Sci; 1974 Sep; 23(1):1-15. PubMed ID: 4277605
    [No Abstract]   [Full Text] [Related]  

  • 12. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals.
    Kihara M; Schmelzer JD; Poduslo JF; Curran GL; Nickander KK; Low PA
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6107-11. PubMed ID: 2068089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats.
    Chen AS; Taguchi T; Sugiura M; Wakasugi Y; Kamei A; Wang MW; Miwa I
    Horm Metab Res; 2004 Mar; 36(3):183-7. PubMed ID: 15057673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine.
    Sagara M; Satoh J; Wada R; Yagihashi S; Takahashi K; Fukuzawa M; Muto G; Muto Y; Toyota T
    Diabetologia; 1996 Mar; 39(3):263-9. PubMed ID: 8721770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats.
    Hanaoka Y; Ohi T; Furukawa S; Furukawa Y; Hayashi K; Matsukura S
    Exp Neurol; 1992 Feb; 115(2):292-6. PubMed ID: 1735473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats.
    Van der Zee CE; Van der Hoop RG; Gispen WH
    Diabetes; 1989 Feb; 38(2):225-30. PubMed ID: 2536628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
    Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
    Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats.
    Moore SA; Peterson RG; Felten DL; O'Connor BL
    J Neurol Sci; 1980 Oct; 48(1):133-52. PubMed ID: 6448276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.